Enliven Therapeutics (ELVN) earnings, Aug 5, 2026: EPS 0%, stock +1.0%
In brief
Enliven Therapeutics reported on Aug 5, 2026. Earnings per share changed 0% year over year, 26.6% below the estimate; revenue 0%. The stock opened with a −0.6% gap and closed the day +1.0% (Aug 6, 2026). The stock is now 28.1% below its 52-week high, +142.1% over 12 months. Next report: Nov 18, 2026.
EPS vs estimate−26.6%
EPS, YoY0%
Revenue, YoY0%
Gap · day−0.6% · +1.0%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 5, 2026 | −0.6% | +1.0% |
Next-quarter estimates, ratings and the ELVN chart are in the terminal.
Open the terminalFAQ
When is Enliven Therapeutics's next earnings report?
Nov 18, 2026. The date comes from daily data and is corrected if the company moves it.
How did Enliven Therapeutics stock react to the report?
Opening gap −0.6%, day's result +1.0%.
Did Enliven Therapeutics's earnings grow?
Earnings per share fell 0% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.